Copper in medicine

被引:120
作者
Brewer, GJ
机构
[1] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA
关键词
D O I
10.1016/S1367-5931(03)00018-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Copper has been found to be causative in several diseases. New findings with the greatest potential for impact in medicine include the use of copper-lowering therapy for antiangiogenesis, antifibrotic and anti-inflammatory purposes. The indication of the role of copper in formation of amyloid plaques in Alzheimer's disease, and successful treatment of an Alzheimer's rodent model by copper chelation are also potentially important. There have also been recent developments in the genetic and non-genetic abnormalities of copper, including the finding of new copper-related genes that potentially could cause disease if mutated.
引用
收藏
页码:207 / 212
页数:6
相关论文
共 47 条
[21]  
2-L
[22]  
BREWER GJ, 2003, IN PRESS J LAB CLIN
[23]  
BREWER GJ, 2001, WILSONS DIS PATIENT
[24]   THE WILSON DISEASE GENE IS A PUTATIVE COPPER TRANSPORTING P-TYPE ATPASE SIMILAR TO THE MENKES GENE [J].
BULL, PC ;
THOMAS, GR ;
ROMMENS, JM ;
FORBES, JR ;
COX, DW .
NATURE GENETICS, 1993, 5 (04) :327-337
[25]   Treatment with a copper-zinc chelator markedly and rapidly inhibits β-amyloid accumulation in Alzheimer's disease transgenic mice [J].
Cherny, RA ;
Atwood, CS ;
Xilinas, ME ;
Gray, DN ;
Jones, WD ;
McLean, CA ;
Barnham, KJ ;
Volitakis, I ;
Fraser, FW ;
Kim, YS ;
Huang, XD ;
Goldstein, LE ;
Moir, RD ;
Lim, JT ;
Beyreuther, K ;
Zheng, H ;
Tanzi, RE ;
Masters, CL ;
Bush, AI .
NEURON, 2001, 30 (03) :665-676
[26]   The role of copper suppression as an antiangiogenic strategy in head and neck squamous cell carcinoma [J].
Cox, C ;
Teknos, TN ;
Barrios, M ;
Brewer, GJ ;
Dick, RD ;
Merajver, SD .
LARYNGOSCOPE, 2001, 111 (04) :696-701
[27]  
COX D, WILSONS DIS
[28]  
FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182
[29]  
FOLKMAN J, 1986, CANCER RES, V46, P467
[30]   Radiotherapy and antiangiogenic TM in lung cancer [J].
Khan, MK ;
Miller, MW ;
Taylor, J ;
Gill, NK ;
Dick, RD ;
Van Golen, K ;
Brewer, GJ ;
Merajver, SD .
NEOPLASIA, 2002, 4 (02) :164-170